Ethambutol/isoniazid/rifampicin

Ethambutol/isoniazid/rifampicin, also known as ethambutol/isoniazid/rifampin, is a fixed-dose combination medication used to treat tuberculosis.[1] It contains ethambutol, isoniazid, and rifampicin.[1] It is used either along or with other anti-tuberculosis medication.[1] It is taken by mouth.[1] Side effects are those of the underlying medications.[1] Use may not be suitable in children.[1]

Ethambutol/isoniazid/rifampicin
Combination of
ethambutolanti-tuberculosis medication
isoniazidanti-tuberculosis medication
rifampicinanti-tuberculosis medication
Clinical data
ATC code
Identifiers
ChemSpider
  • none

It is on the World Health Organization's List of Essential Medicines.[2]

See also

References

  1. World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. p. 142. hdl:10665/44053. ISBN 9789241547659.
  2. World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

Further reading

  • "Ethambutol". Drug Information Portal. U.S. National Library of Medicine.
  • "Isoniazid". Drug Information Portal. U.S. National Library of Medicine.
  • "Rifampin". Drug Information Portal. U.S. National Library of Medicine.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.